System for Localization Tumor Margins During Surgery

描述（由申请人提供）：最近的技术发展和 提高公众对常规乳房X线检查必要性的认识， 导致了小的，通常是不可触及的， 乳腺病变不幸的是，手术工具的发展速度 没有跟上诊断工具的发展， 小的病变仍然是一个困难、耗时的过程， 失败 该提案旨在继续开发一种系统，使外科医生能够 保乳术中准确定位肿瘤边缘位置 手术和针定位乳腺活检程序。在第一阶段， 该系统的原型版本已经构建，并在 模拟乳房病变。该测试表明，该系统具有 有可能提高这些程序的准确性，减少 由于不完全切除或遗漏病变而失败的手术。同相 二、将开发出手持版系统，并在各种 肿瘤的几何形状代表那些在临床实践中遇到的。 拟定商业应用： 这项技术的商业潜力是巨大的。 Creare制作了一个广告 旨在将这项技术推向市场。

DESCRIPTION (Provided by Applicant): Recent technological developments and increased public awareness of the need for routine mammographic screening have resulted in a dramatic increase in the detection of small, often nonpalpable breast lesions. Unfortunately, the pace of development of surgical tools has not kept pace with development of the diagnostic tools and removal of these small lesions remains a difficult, time consuming process that is prone to failure. This proposal addresses continued development of a system to allow surgeons to accurately identify the position of tumor margins during breast conservation surgery and needle-localization breast biopsy procedures. In Phase I, a prototype version of the system was constructed and successfully tested on simulated breast lesions. This testing demonstrated that the system has the potential to increase the accuracy of these procedures and reduce the number of surgeries that fail due to incomplete resections or missed lesions. In Phase II, a handheld version of the system will be developed and tested on a variety of tumor geometries representative of those encountered in clinical practice. PROPOSED COMMERCIAL APPLICATION: The commercial potential of this technology is significant. Creare has formed a commercial partnership intended to bring this technology to market.